Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma with the anti-CD37 radioimmunoconjugate (212)Pb-NNV003

Relapse of chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma after standard of care treatment is common and new therapies are needed. The targeted alpha therapy with (212)Pb-NNV003 presented in this study combines cytotoxic α-particles from (212)Pb, with the anti-CD37 antibody NNV003, targeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Maaland, Astri Fjelde, Saidi, Amal, Torgue, Julien, Heyerdahl, Helen, Stallons, Tania A. Rozgaja, Kolstad, Arne, Dahle, Jostein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080250/
https://www.ncbi.nlm.nih.gov/pubmed/32187209
http://dx.doi.org/10.1371/journal.pone.0230526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080250/
https://www.ncbi.nlm.nih.gov/pubmed/32187209
http://dx.doi.org/10.1371/journal.pone.0230526

Ejemplares similares